Cargando…
Seven-year exclusivity and beyond for drugs of rare diseases in China
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600485/ https://www.ncbi.nlm.nih.gov/pubmed/37900168 http://dx.doi.org/10.3389/fphar.2023.1223056 |
_version_ | 1785125997019922432 |
---|---|
author | Jiang, Yale Huang, Huiyao Zhao, Guo Ma, Peiwen Zhang, Liang Wang, Shuhang Li, Ning |
author_facet | Jiang, Yale Huang, Huiyao Zhao, Guo Ma, Peiwen Zhang, Liang Wang, Shuhang Li, Ning |
author_sort | Jiang, Yale |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10600485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106004852023-10-27 Seven-year exclusivity and beyond for drugs of rare diseases in China Jiang, Yale Huang, Huiyao Zhao, Guo Ma, Peiwen Zhang, Liang Wang, Shuhang Li, Ning Front Pharmacol Pharmacology Frontiers Media S.A. 2023-10-12 /pmc/articles/PMC10600485/ /pubmed/37900168 http://dx.doi.org/10.3389/fphar.2023.1223056 Text en Copyright © 2023 Jiang, Huang, Zhao, Ma, Zhang, Wang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Jiang, Yale Huang, Huiyao Zhao, Guo Ma, Peiwen Zhang, Liang Wang, Shuhang Li, Ning Seven-year exclusivity and beyond for drugs of rare diseases in China |
title | Seven-year exclusivity and beyond for drugs of rare diseases in China |
title_full | Seven-year exclusivity and beyond for drugs of rare diseases in China |
title_fullStr | Seven-year exclusivity and beyond for drugs of rare diseases in China |
title_full_unstemmed | Seven-year exclusivity and beyond for drugs of rare diseases in China |
title_short | Seven-year exclusivity and beyond for drugs of rare diseases in China |
title_sort | seven-year exclusivity and beyond for drugs of rare diseases in china |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600485/ https://www.ncbi.nlm.nih.gov/pubmed/37900168 http://dx.doi.org/10.3389/fphar.2023.1223056 |
work_keys_str_mv | AT jiangyale sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina AT huanghuiyao sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina AT zhaoguo sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina AT mapeiwen sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina AT zhangliang sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina AT wangshuhang sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina AT lining sevenyearexclusivityandbeyondfordrugsofrarediseasesinchina |